• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tumor

bird birds flying humingbirds
Biotech

Hummingbird uses VISTA buzz to secure $290M pact for tumor drug

Hummingbird could one day feather its nest with up to $290 million if its decision to license a phase 2-ready cancer drug to Percheron pays off.
James Waldron Jun 26, 2025 4:53am
Mosaic pattern collage

Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

Apr 24, 2025 10:00am
Three blocks displaying from left to right a person a handshake and another person

Merck KGaA pays $85M for global rights to Abbisko's tumor drug

Apr 1, 2025 7:40am
Abstract 3D Geometric Shapes Cube Blocks Background

Takeda's oncology execs sharpen focus after restructuring

Mar 13, 2025 10:59am
Graphic image of a fishing line looking to hook onto 100 bills underwater

Merck KGaA tacks on Abbisko’s joint tumor med for $70M upfront

Dec 4, 2023 10:26am
An arrow incrementally going up stairs before pointing straight up Blue background

Deciphera's tumor-tackling oral med achieves 40% response rate

Oct 30, 2023 11:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings